Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 1.60
NYSE:HUM's Cash-to-Debt is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. NYSE:HUM: 1.60 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:HUM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.26  Med: 0.81 Max: No Debt
Current: 1.6
Equity-to-Asset 0.34
NYSE:HUM's Equity-to-Asset is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. NYSE:HUM: 0.34 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:HUM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.39 Max: 0.54
Current: 0.34
0.25
0.54
Debt-to-Equity 0.47
NYSE:HUM's Debt-to-Equity is ranked higher than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.66 vs. NYSE:HUM: 0.47 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:HUM' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01  Med: 0.39 Max: 0.9
Current: 0.47
0.01
0.9
Interest Coverage 15.58
NYSE:HUM's Interest Coverage is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. NYSE:HUM: 15.58 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:HUM' s Interest Coverage Range Over the Past 10 Years
Min: 8.21  Med: 14.43 Max: 20.5
Current: 15.58
8.21
20.5
Beneish M-Score: -3.08
WACC vs ROIC
5.54%
99.46%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 5.84
NYSE:HUM's Operating Margin % is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. NYSE:HUM: 5.84 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:HUM' s Operating Margin % Range Over the Past 10 Years
Min: 2.85  Med: 4.77 Max: 6.07
Current: 5.84
2.85
6.07
Net Margin % 3.37
NYSE:HUM's Net Margin % is ranked lower than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. NYSE:HUM: 3.37 )
Ranked among companies with meaningful Net Margin % only.
NYSE:HUM' s Net Margin % Range Over the Past 10 Years
Min: 1.13  Med: 3.05 Max: 3.85
Current: 3.37
1.13
3.85
ROE % 16.79
NYSE:HUM's ROE % is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. NYSE:HUM: 16.79 )
Ranked among companies with meaningful ROE % only.
NYSE:HUM' s ROE % Range Over the Past 10 Years
Min: 5.84  Med: 14.85 Max: 23.54
Current: 16.79
5.84
23.54
ROA % 6.21
NYSE:HUM's ROA % is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. NYSE:HUM: 6.21 )
Ranked among companies with meaningful ROA % only.
NYSE:HUM' s ROA % Range Over the Past 10 Years
Min: 2.45  Med: 6.27 Max: 8.39
Current: 6.21
2.45
8.39
3-Year Revenue Growth Rate 11.60
NYSE:HUM's 3-Year Revenue Growth Rate is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. NYSE:HUM: 11.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:HUM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -26.1  Med: 10 Max: 28.7
Current: 11.6
-26.1
28.7
3-Year EBITDA Growth Rate -2.20
NYSE:HUM's 3-Year EBITDA Growth Rate is ranked lower than
84% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. NYSE:HUM: -2.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:HUM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -46.2  Med: 7.65 Max: 38.5
Current: -2.2
-46.2
38.5
3-Year EPS without NRI Growth Rate -19.30
NYSE:HUM's 3-Year EPS without NRI Growth Rate is ranked lower than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. NYSE:HUM: -19.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:HUM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -49.7  Med: 5.15 Max: 41.9
Current: -19.3
-49.7
41.9
GuruFocus has detected 6 Warning Signs with Humana Inc $NYSE:HUM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:HUM's 30-Y Financials

Financials (Next Earnings Date: 2017-11-08)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

HUM Guru Trades in Q3 2016

John Paulson 79,500 sh (New)
Daniel Loeb 1,400,000 sh (New)
Steven Cohen 32,700 sh (New)
Paul Tudor Jones 103,861 sh (New)
Diamond Hill Capital 228,660 sh (New)
Joel Greenblatt 10,396 sh (+181.05%)
Jim Simons 913,704 sh (+29.27%)
Larry Robbins 9,529,175 sh (+9.93%)
George Soros 82,700 sh (unchged)
Jeremy Grantham 343,000 sh (unchged)
George Soros Sold Out
David Einhorn Sold Out
Mario Gabelli 26,945 sh (-0.46%)
Jeremy Grantham 649,537 sh (-0.95%)
Pioneer Investments 550,039 sh (-6.27%)
Andreas Halvorsen 640,646 sh (-21.09%)
HOTCHKIS & WILEY 527,545 sh (-45.33%)
» More
Q4 2016

HUM Guru Trades in Q4 2016

Daniel Loeb 2,400,000 sh (+71.43%)
Jim Simons 1,460,300 sh (+59.82%)
Joel Greenblatt 16,241 sh (+56.22%)
Andreas Halvorsen 737,962 sh (+15.19%)
Jeremy Grantham 343,000 sh (unchged)
HOTCHKIS & WILEY Sold Out
John Paulson Sold Out
Diamond Hill Capital Sold Out
Jeremy Grantham 563,314 sh (-13.27%)
Pioneer Investments 454,560 sh (-17.36%)
Steven Cohen 25,700 sh (-21.41%)
Mario Gabelli 20,183 sh (-25.10%)
Larry Robbins 6,313,790 sh (-33.74%)
Paul Tudor Jones 3,300 sh (-96.82%)
» More
Q1 2017

HUM Guru Trades in Q1 2017

Vanguard Health Care Fund 215,600 sh (New)
Steve Mandel 1,184,119 sh (New)
Leon Cooperman 125,000 sh (New)
Alan Fournier 208,300 sh (New)
Eaton Vance Worldwide Health Sciences Fund 69,017 sh (New)
Steven Cohen 211,128 sh (+721.51%)
Jim Simons 2,691,700 sh (+84.33%)
Joel Greenblatt 19,680 sh (+21.17%)
Pioneer Investments 472,094 sh (+3.86%)
Daniel Loeb 500,000 sh (unchged)
Larry Robbins 5,315,768 sh (-15.81%)
Jeremy Grantham 431,861 sh (-23.34%)
Andreas Halvorsen 440,766 sh (-40.27%)
Paul Tudor Jones 1,800 sh (-45.45%)
Daniel Loeb 925,000 sh (-61.46%)
Mario Gabelli 3,800 sh (-81.17%)
» More
Q2 2017

HUM Guru Trades in Q2 2017

Lee Ainslie 16,610 sh (New)
Paul Tudor Jones 5,229 sh (+190.50%)
Mario Gabelli 5,175 sh (+36.18%)
Jeremy Grantham 569,109 sh (+31.78%)
Joel Greenblatt 20,914 sh (+6.27%)
Jim Simons 2,731,100 sh (+1.46%)
Eaton Vance Worldwide Health Sciences Fund 83,440 sh (+20.90%)
Vanguard Health Care Fund 215,600 sh (unchged)
Leon Cooperman Sold Out
Alan Fournier Sold Out
Steve Mandel Sold Out
Pioneer Investments 437,224 sh (-7.39%)
Daniel Loeb 750,000 sh (-18.92%)
Andreas Halvorsen 345,907 sh (-21.52%)
Steven Cohen 70,900 sh (-66.42%)
Larry Robbins 717,470 sh (-86.50%)
» More
» Details

Insider Trades

Latest Guru Trades with HUM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-06-30 Add 6.27%$206.14 - $240.62 $ 238.035%20,914
Mario Gabelli 2017-06-30 Add 36.18%$206.14 - $240.62 $ 238.035%5,175
Steve Mandel 2017-06-30 Sold Out 1.28%$206.14 - $240.62 $ 238.035%0
Leon Cooperman 2017-06-30 Sold Out 1.04%$206.14 - $240.62 $ 238.035%0
Steve Mandel 2017-03-31 New Buy1.28%$195.24 - $219.25 $ 238.0315%1,184,119
Vanguard Health Care Fund 2017-03-31 New Buy0.1%$195.24 - $219.25 $ 238.0315%215,600
Leon Cooperman 2017-03-31 New Buy1.04%$195.24 - $219.25 $ 238.0315%125,000
Joel Greenblatt 2017-03-31 Add 21.17%0.01%$195.24 - $219.25 $ 238.0315%19,680
Mario Gabelli 2017-03-31 Reduce -81.17%0.02%$195.24 - $219.25 $ 238.0315%3,800
Mario Gabelli 2016-12-31 Reduce -25.10%0.01%$165.31 - $216.76 $ 238.0325%20,183
Joel Greenblatt 2016-12-31 Add 56.22%0.01%$165.31 - $216.76 $ 238.0325%16,241
John Paulson 2016-12-31 Sold Out 0.15%$165.31 - $216.76 $ 238.0325%0
HOTCHKIS & WILEY 2016-12-31 Sold Out 0.39%$165.31 - $216.76 $ 238.0325%0
HOTCHKIS & WILEY 2016-09-30 Reduce -45.33%0.34%$153.38 - $180.86 $ 238.0337%527,545
John Paulson 2016-09-30 New Buy0.15%$153.38 - $180.86 $ 238.0337%79,500
Mario Gabelli 2016-09-30 Reduce -0.46%$153.38 - $180.86 $ 238.0337%26,945
Joel Greenblatt 2016-09-30 Add 181.05%0.01%$153.38 - $180.86 $ 238.0337%10,396
George Soros 2016-09-30 Sold Out 0.21%$153.38 - $180.86 $ 238.0337%0
David Einhorn 2016-09-30 Sold Out 1.27%$153.38 - $180.86 $ 238.0337%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 621610    SIC: 6324
Compare:NAS:ESRX, NYSE:CI, NYSE:ANTM, NYSE:AET, NYSE:CNC, NYSE:WCG, NYSE:MOH, NAS:MGLN, NAS:HIIQ, OTCPK:OPRX, NAS:CNXR, OTCPK:WCUI, OTCPK:HFRN, NYSE:CVS, NYSE:UNH » details
Traded in other countries:HUM.Germany,
Headquarter Location:USA
Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.

Humana is one of the largest and best-known providers of Medicare Advantage plans in the U.S. The firm specializes in providing government-sponsored plans, with close to three fourths of its membership tied to Medicare, Medicaid, or some other form of government healthcare program. Humana is also building out an extensive provider network in key geographic areas in order to control the use and cost of healthcare services. These network and the firm's brand name will also make it a major player in the nascent public exchange market.

Top Ranked Articles about Humana Inc

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Humana Inc. (HUM)
Amgen in Collaboration With Humana for Patients' Benefit The companies will also have a deep focus into specific therapeutic areas
Amgen (AMGN) has informed the market through a news release published on its website that it will collaborate with Humana (HUM) to uncover opportunities for the improvement of patient health outcomes and for the improvement of the health care system’s efficiency. Read more...
Amgen And Humana Partner For Improved Health Outcomes And Efficiency
PriceWatch Alert: covered-call reports for Apple, AMC Entertainment Holdings, Humana, PharMerica Corporation and SodaStream
Eaton Vance Worldwide Health Sciences Fund Adds 4 Stocks to Portfolio Health care fund reports fourth-quarter activity
Jason Kritzer, vice president of Eaton Vance Management, invests in companies with a bottom-up, proprietary research approach. The portfolio manager of the Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) invested in four companies during the first quarter: Aetna Inc. (NYSE:AET), Humana Inc. (NYSE:HUM), Hologic Inc. (NASDAQ:HOLX) and Teleflex Inc. (NYSE:TFX) Read more...
Leon Cooperman's Top 5 New Buys Omega Advisers updates first-quarter portfolio
Leon Cooperman (Trades, Portfolio), who leads Omega Advisers, a $3.6 billion firm, purchased 30 new stocks in the first quarter. Read more...
Insiders Sell Amazon, Humana, MasterCard Insiders' largest buys and sales of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+” the duration to “May 2017” and All Insider Sales to “$5,000,000+.” Read more...
Daniel Loeb’s Value-Seeking Journey This guru investor has gone from being a brash activist to an observer of the really big picture
Over slightly more than two decades, Loeb’s Master Fund has returned average annual returns of 17.9%. Read more...
Analysts Release New Health Care Stock Ratings Jeffries downgrades Amgen to hold from buy
Analysts released new ratings for some health care stocks recently. Read more...
Trump's New Health Care Frontier Will reform have investors looking toward telemedicine?
A Donald Trump presidency has many more eyes focused on health care and the adjustment in health care reform that has been frequently discussed by the president. For investors, this tumultuous time could actually be opening up much greater opportunities not only in the health care sector but also the medical technology and telemedicine industries. Read more...

Ratios

vs
industry
vs
history
PE Ratio 19.48
HUM's PE Ratio is ranked lower than
68% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. HUM: 19.48 )
Ranked among companies with meaningful PE Ratio only.
HUM' s PE Ratio Range Over the Past 10 Years
Min: 4.26  Med: 11.16 Max: 53.01
Current: 19.48
4.26
53.01
Forward PE Ratio 19.65
HUM's Forward PE Ratio is ranked lower than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.39 vs. HUM: 19.65 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 19.48
HUM's PE Ratio without NRI is ranked lower than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. HUM: 19.48 )
Ranked among companies with meaningful PE Ratio without NRI only.
HUM' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.26  Med: 11.16 Max: 53.01
Current: 19.48
4.26
53.01
Price-to-Owner-Earnings 6.71
HUM's Price-to-Owner-Earnings is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.73 vs. HUM: 6.71 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HUM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.73  Med: 7.41 Max: 76.26
Current: 6.71
2.73
76.26
PB Ratio 3.16
HUM's PB Ratio is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.78 vs. HUM: 3.16 )
Ranked among companies with meaningful PB Ratio only.
HUM' s PB Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.81 Max: 3.82
Current: 3.16
0.71
3.82
PS Ratio 0.66
HUM's PS Ratio is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. HUM: 0.66 )
Ranked among companies with meaningful PS Ratio only.
HUM' s PS Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.39 Max: 0.72
Current: 0.66
0.11
0.72
Price-to-Free-Cash-Flow 6.69
HUM's Price-to-Free-Cash-Flow is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. HUM: 6.69 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HUM' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.77  Med: 7.12 Max: 669.94
Current: 6.69
2.77
669.94
Price-to-Operating-Cash-Flow 6.12
HUM's Price-to-Operating-Cash-Flow is ranked higher than
80% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.27 vs. HUM: 6.12 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HUM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.5  Med: 6.2 Max: 53.04
Current: 6.12
2.5
53.04
EV-to-EBIT 6.96
HUM's EV-to-EBIT is ranked higher than
80% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.25 vs. HUM: 6.96 )
Ranked among companies with meaningful EV-to-EBIT only.
HUM' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.7  Med: 3.6 Max: 14.4
Current: 6.96
-0.7
14.4
EV-to-EBITDA 6.10
HUM's EV-to-EBITDA is ranked higher than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.19 vs. HUM: 6.10 )
Ranked among companies with meaningful EV-to-EBITDA only.
HUM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.6  Med: 3.1 Max: 11.4
Current: 6.1
-0.6
11.4
EV-to-Revenue 0.43
HUM's EV-to-Revenue is ranked higher than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.77 vs. HUM: 0.43 )
Ranked among companies with meaningful EV-to-Revenue only.
HUM' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.2 Max: 0.5
Current: 0.43
0.1
0.5
PEG Ratio 8.48
HUM's PEG Ratio is ranked lower than
93% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. HUM: 8.48 )
Ranked among companies with meaningful PEG Ratio only.
HUM' s PEG Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.63 Max: 11.02
Current: 8.48
0.15
11.02
Shiller PE Ratio 29.71
HUM's Shiller PE Ratio is ranked lower than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.81 vs. HUM: 29.71 )
Ranked among companies with meaningful Shiller PE Ratio only.
HUM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.68  Med: 21.57 Max: 70.74
Current: 29.71
10.68
70.74

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.58
HUM's Dividend Yield % is ranked lower than
87% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. HUM: 0.58 )
Ranked among companies with meaningful Dividend Yield % only.
HUM' s Dividend Yield % Range Over the Past 10 Years
Min: 0.3  Med: 0.75 Max: 1.61
Current: 0.58
0.3
1.61
Dividend Payout Ratio 0.11
HUM's Dividend Payout Ratio is ranked higher than
83% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. HUM: 0.11 )
Ranked among companies with meaningful Dividend Payout Ratio only.
HUM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09  Med: 0.14 Max: 0.21
Current: 0.11
0.09
0.21
3-Year Dividend Growth Rate -6.70
HUM's 3-Year Dividend Growth Rate is ranked lower than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. HUM: -6.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
HUM' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 14
Current: -6.7
0
14
Forward Dividend Yield % 0.67
HUM's Forward Dividend Yield % is ranked lower than
93% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.65 vs. HUM: 0.67 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.67
HUM's 5-Year Yield-on-Cost % is ranked lower than
90% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.04 vs. HUM: 0.67 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HUM' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.35  Med: 0.88 Max: 1.88
Current: 0.67
0.35
1.88
3-Year Average Share Buyback Ratio 1.00
HUM's 3-Year Average Share Buyback Ratio is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. HUM: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HUM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2  Med: -0.4 Max: 3
Current: 1
-2
3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 4.48
HUM's Price-to-Tangible-Book is ranked higher than
75% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.27 vs. HUM: 4.48 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HUM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.32  Med: 3.23 Max: 12.29
Current: 4.48
1.32
12.29
Price-to-Intrinsic-Value-Projected-FCF 1.20
HUM's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. HUM: 1.20 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HUM' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.3  Med: 0.94 Max: 2.07
Current: 1.2
0.3
2.07
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.71
HUM's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
80% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. HUM: 1.71 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
HUM' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.27  Med: 0.56 Max: 4.44
Current: 1.71
0.27
4.44
Price-to-Median-PS-Value 1.69
HUM's Price-to-Median-PS-Value is ranked lower than
82% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. HUM: 1.69 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HUM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.37  Med: 1.02 Max: 13.28
Current: 1.69
0.37
13.28
Price-to-Peter-Lynch-Fair-Value 2.57
HUM's Price-to-Peter-Lynch-Fair-Value is ranked lower than
92% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. HUM: 2.57 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
HUM' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.23  Med: 0.67 Max: 15.34
Current: 2.57
0.23
15.34
Price-to-Graham-Number 1.97
HUM's Price-to-Graham-Number is ranked higher than
83% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.77 vs. HUM: 1.97 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HUM' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.65  Med: 1.7 Max: 6.81
Current: 1.97
0.65
6.81
Earnings Yield (Greenblatt) % 14.37
HUM's Earnings Yield (Greenblatt) % is ranked higher than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.85 vs. HUM: 14.37 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HUM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3390  Med: 27.75 Max: 4111
Current: 14.37
-3390
4111
Forward Rate of Return (Yacktman) % 11.39
HUM's Forward Rate of Return (Yacktman) % is ranked lower than
80% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. HUM: 11.39 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HUM' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.9  Med: 27.25 Max: 51.5
Current: 11.39
6.9
51.5

More Statistics

Revenue (TTM) (Mil) $53,868.00
EPS (TTM) $ 12.24
Beta0.62
Short Percentage of Float1.80%
52-Week Range $163.50 - 259.76
Shares Outstanding (Mil)144.52

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 53,998 56,684 60,257
EPS ($) 11.44 12.23 13.58
EPS without NRI ($) 11.44 12.23 13.58
EPS Growth Rate
(Future 3Y To 5Y Estimate)
11.76%
Dividends per Share ($) 1.47 1.48 1.60

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}